All News

gout.bigtoe1.jpg (keep)

Interleukin-37 Targeting in Gout

d Jack Cush, MD

The Annals of Rheumatic Disease reports that interleukin- 27 (IL-37) may play an important role in the pathogenesis of gout, paving the way for future therapy with recombinant IL-37 in gouty arthritis.

Read Article
RN.podcast.resized.jpg

RheumNow Podcast- Methotrexate Mechanisms (2.28.20)

d Jack Cush, MD

Dr Jack Cush Reviews the news and journal articles from the past week on RheumNow.com

Read Article
exhausted.jpg (keep)

Fatigue Looms Large in Lupus

d RheumNow

Fatigue is an important component of the disease experience in systemic lupus erythematosus (SLE), and can have a profound impact on patients' perception of well-being, Italian researchers reported.

Read Article
D2R7K_0WoAA-KXG.jpg

Why You Should Come to RheumNow Live March 13th

d Jack Cush, MD

RheumNow Live kicks off its second annual meeting - a little, big meeting in Fort Worth - in just 2 weeks and I think you should be there.

Read Article
bariatric.surgery.obesity.jpg (keep)

Bariatric Surgery Improves Rheumatoid Activity

d Jack Cush, MD

Obesity is a risk factor for the onset of rheumatoid arthritis (RA) and may also an impediment to optimal DMARD and biologic responses.  A new study has shown that after 1 year, obese RA patients undergoing bariatric surgery with weight loss had significantly lower disease activity.

Read Article
pregnant.baby_.hands_.jpg

ACR Releases Reproductive Health Guidelines for Rheumatic Diseases

d Jack Cush, MD

Today, the American College of Rheumatology (ACR) published the 2020 Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.

Read Article
Vitamin D deficiency is associated with lumbar disc disease and LBP in postmenopausal women; moresoe w/ very low vitamin D concentration < 10 ng/mL - study of 232 postmenopausal women https://t.co/Kmu8nMOaf7

Links:

Dr. John Cush RheumNow ( View Tweet)

U.S. FDA Accepts Regulatory Submission for Tanezumab, an NGF inhibitor, for the Treatment for Patients with Chronic Pain Due to Moderate-to-Severe Osteoarthritis https://t.co/9NsESTnn4S

Links:

Dr. John Cush RheumNow ( View Tweet)

"He has all of the virtues I dislike and none of the vices I admire." -Winston Churchill

Dr. John Cush RheumNow ( View Tweet)

QD Clinic - Cases, insights and RNL info. Listen to the podcasts on iTunes or here https://t.co/V60JN2ZdYF

Links:

Dr. John Cush RheumNow ( View Tweet)

The RHeumNow Podcast is up. https://t.co/pD2fWDsCOJ Checkout the podcast >> https://t.co/x0RytGbNYi

Links:

Dr. John Cush RheumNow ( View Tweet)

Long term safety of Sarilumab reviewed. 2887 SAR pts on Combo and 471 on SAR mono Rx for up to 7.3 yrs (8188 PYs). SAEs 9.4 & 6.7/100PY; SIE 3.7 &, H zoster (0.5-0.6/100PY), GI perforations < 0.1/100PY & Cancer 0.7-.6. ANC <1000 in 13-15% https://t.co/YA2TKCdpGY

Links:

Dr. John Cush RheumNow ( View Tweet)

Study of metformin in NON-diabetics w/ inflammatory disease on Pred >20/d shows metformin to to reduce pneumonia, serious infections, markers of carbohydrate/lipid,/liver & bone metabolism (vs PBO) but had no effect on truncal fat https://t.co/8RE2fJMkv9

Links:

Dr. John Cush RheumNow ( View Tweet)

Prof Dinesh Khanna has an algorithm for SSc ILD. High CRP is a risk. HRCT is only low radiation so use for dx and prognosis #CRA2020 great lecture @RheumNow @earlyarthritis @sclerodermaUM https://t.co/VgltxqFKCo
Janet Pope Janetbirdope ( View Tweet)
Syphilis = The great imitator! Dx further muddled by periods of active and inactive disease. 2 main diagnostic algorithms that rely on serology, and both have pitfalls! @LCalabreseDO @NEJM @HealioRheum https://t.co/PvIG8hX0Ht https://t.co/EFTBYhK8QF

Links:

Cassandra Calabrese CCalabreseDO ( View Tweet)
Anyone else getting hysterical patients? They want to stop their biologic because they “know” they are going to get #COVID2019 . I tell them their risk of their disease flaring off med is 100% while their risk for the infection is <1%. What do you tell your patients? @RheumNow https://t.co/2I8kVlKLOC

Links:

k dao KDAO2011 ( View Tweet)

Hospital for Special Surgery (HSS) announced the appointment of S. Louis Bridges, Jr., MD, PhD, as the new Physician-in-Chief and Chair of the Division of Rheumatology, effective September 1, 2020. Dr. Bridges succeeds Mary K. Crow, MD https://t.co/TQ55jMOXHj

Links:

Dr. John Cush RheumNow ( View Tweet)

HIP ATTACK trial assessed if accelerated surgery could reduce mortality & complications. 2970 Pts recv accelerated surgery (6 hr) vs standard care (24hrs). Risk of death (9-10%) & infection was the same; thus accelerated surgery did not lower risk https://t.co/Z4ld0RoRSX

Links:

Dr. John Cush RheumNow ( View Tweet)

The use of cannabis in the past year by adults 65 years and older in the United States increased sharply from 0.4% in 2006 and 2007 to 2.9% in 2015 and 2016 https://t.co/RCVsKvGBI5

Links:

Dr. John Cush RheumNow ( View Tweet)

"Difficulties mastered are opportunities won." - WInston Churchill

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×